Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Lexicon Genetics (LEXG), which is developing knockout mice for target validation and drug discovery, on Thursday raised $220 million in its
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury